Top Markets
Coin of the day
Celltrion Healthcare Co., Ltd. Celltrion Healthcare Co., Ltd.

Celltrion Healthcare Co., Ltd.

091990
Classement en actions #2264
Celltrion Healthcare Co., Ltd. is a global pharmaceutical company focused on... Celltrion Healthcare Co., Ltd. is a global pharmaceutical company focused on the development, manufacturing, and distribution of biosimilar and biological therapeutic agents for patients around the globe. Its product lineup includes Remsima, a monoclonal antibody biosimilar used to treat various inflammatory and autoimmune diseases such as rheumatoid arthritis, ankylosing spondylitis, ulcerative colitis, Crohn's disease in both adults and children, psoriasis, and psoriatic arthritis. Another significant offering, Truxima, targets conditions like lymphoma, chronic lymphocytic leukemia, Wegener's granulomatosis, microscopic polyangiitis, and rheumatoid arthritis. Herzuma is prescribed for metastatic breast cancer, early-stage breast cancer, and metastatic gastric cancer. Additionally, Remsima SC provides a treatment option for rheumatoid arthritis. Founded in 1999, the enterprise was initially known as Nexol, Inc. before rebranding to Celltrion Healthcare Co., Ltd. in March 2009. The firm's corporate headquarters are situated in Incheon, South Korea.
Prix de l'action
$57.75
Dernière synchronisation: 2024-01-11
Capitalisation boursière
$9.42B
Changement (1 jour)
-0.25%
Changement (1 an)
0.00%
Pays
KR
Échange Celltrion Healthcare Co., Ltd. (091990)

Catégorie

Historique du prix de l'action pour Celltrion Healthcare Co., Ltd. (091990)
Prix de clôture le plus élevé : $57.82 le 2024-01-01

Prix de clôture le plus bas : $74.26 le 2021-10-01
Historique du prix de l'action de Celltrion Healthcare Co., Ltd. de 2021 à 2026
Performance annuelle du prix de l'action
Année Performance
2024 1.85%
2023 14.18%
2022 -28.39%
2021 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$552.62 42.08%
US
$1.02K 50.90%
NL
$155.33 512.75%
US
$122.47 -12.71%
AU
$772.27 8.67%
CH